DaVita Inc. (DVA) |
|
81.11 1.73 (2.18%)
|
03-31 16:00 |
|
Open: |
79.86 |
Pre. Close: |
79.38 |
|
High:
|
81.2 |
Low:
|
79.18 |
|
Volume:
|
603,421 |
Market Cap:
|
7,332(M) |
|
|
|
Technical analysis |
as of: 2023-03-31 4:18:10 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 98.7 One year: 115.29 |
| Support: |
Support1: 77.52 Support2: 73.19 |
| Resistance: |
Resistance1: 84.51 Resistance2: 98.7 |
| Pivot: |
77.35  |
| Moving Average: |
MA(5): 78.69 MA(20): 77.41 
MA(100): 77.19 MA(250): 86.24 |
| MACD: |
MACD(12,26): -0.4 Signal(9): -1 |
| Stochastic oscillator: |
%K(14,3): 91.8 %D(3): 80 |
| RSI: |
RSI(14): 58.6 |
| 52-week: |
High: 124.8 Low: 65.27 |
| Average Vol(K): |
3-Month: 652 (K) 10-Days: 472 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ DVA ] has closed Bollinger Bands are 38.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
79.91 - 80.14 |
80.14 - 80.41 |
|
Low:
|
78.4 - 78.69 |
78.69 - 79.02 |
|
Close:
|
78.87 - 79.31 |
79.31 - 79.8 |
|
Company Description |
|
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. |
Headline News |
Sat, 01 Apr 2023
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new ... - PR Newswire
Fri, 31 Mar 2023
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Fri, 31 Mar 2023
Inlet Private Wealth LLC Reduces Stake in DaVita Inc. (NYSE:DVA) - MarketBeat
Sat, 25 Mar 2023
Romano Brothers AND Company Sells 1375 Shares of DaVita Inc ... - MarketBeat
Tue, 21 Mar 2023
Robeco Institutional Asset Management B.V. Has $4.33 Million ... - MarketBeat
Thu, 16 Mar 2023
May 19th Options Now Available For DaVita (DVA) - Nasdaq
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Care Facilities |
| Shares Out. |
90 (M) |
| Shares Float |
90 (M) |
|
% Held by Insiders
|
3 (%) |
|
% Held by Institutions
|
88.6 (%) |
|
Shares Short
|
2,930 (K) |
|
Shares Short P.Month
|
2,720 (K) |
Stock Financials |
|
EPS
|
5.71 |
|
EPS Est Next Qtl
|
0.93 |
|
EPS Est This Year
|
3.58 |
|
EPS Est Next Year
|
3.78 |
|
Book Value (p.s.)
|
7.88 |
|
Profit Margin (%)
|
4.8 |
|
Operating Margin (%)
|
11.3 |
|
Return on Assets (ttm)
|
4.8 |
|
Return on Equity (ttm)
|
33.4 |
|
Qtrly Rev. Growth
|
-0.9 |
|
Gross Profit (p.s.)
|
37.61 |
|
Sales Per Share
|
128.42 |
|
EBITDA (p.s.)
|
22.67 |
|
Qtrly Earnings Growth
|
-59 |
|
Operating Cash Flow
|
1,560 (M) |
|
Levered Free Cash Flow
|
832 (M) |
Stock Valuations |
|
PE Ratio
|
14.18 |
|
PEG Ratio
|
-7.5 |
|
Price to Book value
|
10.29 |
|
Price to Sales
|
0.63 |
|
Price to Cash Flow
|
4.7 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
